Drug Impact

Our proprietary technology ensures preservation of human TiME,

to ascertain immunomodulatory strategies

Our customizable assay system provides a flexible and comprehensive  approach to prioritization of combinatorial strategies

Our platform's integrated phenotypic outcome and multi-omic data are useful in understanding  the potential mechanisms of action that underlie a response of interest

A variety of comprehensive readouts allow for identification of biomarkers that could potentially differentiate likely response to drug candidates and optimize patient stratification for clinical trials